SLC47A2
Basic information
Region (hg38): 17:19678288-19718979
Links
Phenotypes
GenCC
Source:
ClinVar
This is a list of variants' phenotypes submitted to
Variants pathogenicity by type
Statistics on ClinVar variants can assist in determining whether a specific variant type in the SLC47A2 gene is commonly pathogenic or not.
In the table, we include only reliable ClinVar variants with their consequences to MANE Select, Mane Plus Clinical transcripts, or transcripts with TSL equals 1. Click the count to view the source variants.
Warning: slight differences between displayed counts and the number of variants in ClinVar may occur, primarily due to (1) the application of a different transcript and/or consequence by our variant effect predictor or (2) differences in clinical significance: we classify Benign/Likely benign variants as Likely benign and Pathogenic/Likely pathogenic variants as Likely pathogenic.
Variant type | Pathogenic | Likely pathogenic | VUS | Likely benign | Benign | Sum |
---|---|---|---|---|---|---|
synonymous | 2 | |||||
missense | 32 | 34 | ||||
nonsense | 0 | |||||
start loss | 0 | |||||
frameshift | 0 | |||||
inframe indel | 0 | |||||
splice donor/acceptor (+/-2bp) | 0 | |||||
splice region | 0 | |||||
non coding | 0 | |||||
Total | 0 | 0 | 32 | 3 | 1 |
Variants in SLC47A2
This is a list of pathogenic ClinVar variants found in the SLC47A2 region.
You can filter this list by clicking the number of variants in the Variants pathogenicity by type table.
Position | Type | Phenotype | Significance | ClinVar |
---|---|---|---|---|
17-19678714-G-A | not specified | Uncertain significance (Dec 06, 2022) | ||
17-19678741-G-A | not specified | Uncertain significance (Jun 23, 2021) | ||
17-19678744-G-A | not specified | Likely benign (Dec 20, 2022) | ||
17-19678765-C-T | not specified | Uncertain significance (Feb 28, 2023) | ||
17-19678766-G-A | not specified | Uncertain significance (Feb 21, 2024) | ||
17-19678791-T-C | Likely benign (Nov 01, 2024) | |||
17-19678815-G-A | Likely benign (Sep 01, 2022) | |||
17-19678846-A-C | not specified | Uncertain significance (Oct 10, 2023) | ||
17-19678848-G-C | not specified | Uncertain significance (Jun 16, 2023) | ||
17-19678867-T-G | not specified | Uncertain significance (Jul 19, 2023) | ||
17-19678898-C-G | not specified | Uncertain significance (Aug 22, 2023) | ||
17-19681439-G-C | Benign (Oct 01, 2024) | |||
17-19681564-G-A | not specified | Uncertain significance (Sep 20, 2023) | ||
17-19681583-G-T | not specified | Uncertain significance (Jul 28, 2021) | ||
17-19681594-A-T | not specified | Uncertain significance (Mar 13, 2023) | ||
17-19681636-T-G | not specified | Uncertain significance (Jul 19, 2022) | ||
17-19681658-C-T | Benign (Sep 01, 2024) | |||
17-19702608-G-C | not specified | Uncertain significance (Jul 07, 2022) | ||
17-19703134-C-T | not specified | Uncertain significance (Mar 06, 2023) | ||
17-19704161-G-C | not specified | Uncertain significance (Dec 06, 2021) | ||
17-19705444-T-A | not specified | Uncertain significance (Jun 02, 2024) | ||
17-19705471-C-A | not specified | Uncertain significance (Jun 21, 2022) | ||
17-19705472-C-A | not specified | Uncertain significance (Jun 21, 2022) | ||
17-19706666-T-C | not specified | Uncertain significance (Apr 29, 2024) | ||
17-19706698-A-G | not specified | Uncertain significance (Apr 13, 2023) |
GnomAD
Source:
Gene | Type | Bio Type | Transcript | Coding Exons | Length |
---|---|---|---|---|---|
SLC47A2 | protein_coding | protein_coding | ENST00000325411 | 17 | 40692 |
pLI Probability LOF Intolerant | pRec Probability LOF Recessive | Individuals with no LOFs | Individuals with Homozygous LOFs | Individuals with Heterozygous LOFs | Defined | p |
---|---|---|---|---|---|---|
9.28e-15 | 0.132 | 125578 | 0 | 170 | 125748 | 0.000676 |
Z-Score | Observed | Expected | Observed/Expected | Mutation Rate | Total Possible in Transcript | |
---|---|---|---|---|---|---|
Missense | 0.346 | 326 | 344 | 0.948 | 0.0000192 | 3850 |
Missense in Polyphen | 109 | 116.3 | 0.93725 | 1283 | ||
Synonymous | 0.189 | 145 | 148 | 0.980 | 0.00000924 | 1269 |
Loss of Function | 0.970 | 25 | 30.8 | 0.811 | 0.00000150 | 333 |
LoF frequencies by population
Ethnicity | Sum of pLOFs | p |
---|---|---|
African & African-American | 0.00174 | 0.00174 |
Ashkenazi Jewish | 0.000913 | 0.000893 |
East Asian | 0.000117 | 0.000109 |
Finnish | 0.000240 | 0.000231 |
European (Non-Finnish) | 0.000789 | 0.000774 |
Middle Eastern | 0.000117 | 0.000109 |
South Asian | 0.000550 | 0.000523 |
Other | 0.00124 | 0.00114 |
dbNSFP
Source:
- Function
- FUNCTION: Solute transporter for tetraethylammonium (TEA), 1- methyl-4-phenylpyridinium (MPP), cimetidine, N-methylnicotinamide, metformin, creatinine, guanidine, procainamide, topotecan, estrone sulfate, acyclovir, and ganciclovir. Responsible for the secretion of cationic drugs across the brush border membranes. {ECO:0000269|PubMed:16807400, ECO:0000269|PubMed:16996621, ECO:0000269|PubMed:17509534}.;
- Pathway
- Bile salt and organic anion SLC transporters;Transport of bile salts and organic acids, metal ions and amine compounds;SLC-mediated transmembrane transport;Transport of small molecules
(Consensus)
Recessive Scores
- pRec
- 0.0870
Intolerance Scores
- loftool
- 0.967
- rvis_EVS
- -0.84
- rvis_percentile_EVS
- 11.28
Haploinsufficiency Scores
- pHI
- 0.0335
- hipred
- N
- hipred_score
- 0.112
- ghis
- 0.421
Essentials
- essential_gene_CRISPR
- N
- essential_gene_CRISPR2
- N
- essential_gene_gene_trap
- N
- gene_indispensability_pred
- N
- gene_indispensability_score
- 0.341
Gene Damage Prediction
All | Recessive | Dominant | |
---|---|---|---|
Mendelian | Medium | Medium | Medium |
Primary Immunodeficiency | Medium | Medium | Medium |
Cancer | Medium | Medium | Medium |
Mouse Genome Informatics
- Gene name
- Slc47a2
- Phenotype
- behavior/neurological phenotype (the observable actions or reactions of mammalian organisms that are manifested through development and lifespan);
Gene ontology
- Biological process
- drug transmembrane transport;drug export;transmembrane transport
- Cellular component
- plasma membrane;integral component of membrane
- Molecular function
- drug transmembrane transporter activity;drug:proton antiporter activity